Shankar Musunuri
Förmögenhet: 7 M $ per 2026-08-31
Förmögenhet: 7 M $ per 2026-08-31
Shankar Musunuri founded Nuron Biotech, Inc. in 2009, where he worked as President, Chief Executive Officer & Director in 2013, Ocugen, Inc. in 2013, where he worked as Chairman & Chief Executive Officer, Ocugen, Inc. in 2013, where he is working as Chairman & Chief Executive Officer from 2023, and Ocugen OpCo, Inc. in 2013, where he is working as Executive Chairman & Chief Executive Officer from 2015.
Dr. Musunuri also currently works at OrthoCellix, Inc., as President & Secretary.
Dr. Musunuri also formerly worked at Pfizer Inc., as Senior Director-Global Technology Transfer from 1996 to 2010, Wyeth LLC, as Principal, and Amylin Pharmaceuticals, Inc., as Principal in 1996.
Dr. Musunuri received his doctorate degree from the University of Connecticut and Masters Business Admin degree from The Fuqua School of Business.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
OCUGEN INC 1,64 % | 2026-09-09 | 5 575 232 ( 1,64 % ) | 7 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| OCUGEN, INC. | Verkställande Direktör | 2019-09-27 |
Ocugen OpCo, Inc. | Verkställande Direktör | 2015-05-01 |
| Företag | Position | Slut |
|---|---|---|
| PFIZER INC. | Företagsledare/Principal | 2010-01-01 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Företagsledare/Principal | 1996-01-01 |
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical which develops drugs | Verkställande Direktör | - |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Företagsledare/Principal | - |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Develops vaccines for the prevention and treatment of infectious diseases | Grundare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Develops vaccines for the prevention and treatment of infectious diseases | Health Technology |
The Fuqua School of Business
The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical which develops drugs | Health Technology |
Ocugen, Inc.
Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
Ocugen OpCo, Inc. |
Välj din utgåva
All finansiell information anpassad till den nationella nivån